Shares of Yatharth Hospital & Trauma Care Services witnessed explosive bullish momentum during Thursday's trading session, surging by as much as 10% to log a fresh 52-week peak. The stock touched an intraday high of ₹1,083.6 on the National Stock Exchange and BSE, extending its continuous rally into a third consecutive trading session. The aggressive buying interest was catalyzed by a landmark corporate development: marquee global private equity buyout firm Advent International has entered into a definitive agreement to infuse ₹3,150 crore of fresh growth capital into the multi-specialty healthcare provider. The massive institutional capital commitment has propelled the company's overall market capitalization past the ₹10,300 crore mark, underscoring strong investor confidence in the chain's regional expansion roadmap.

Mega Private Equity Infusion: Advent International to Pick Up 24.9% Equity Stake

According to an official regulatory filing submitted by Yatharth Hospital to stock exchanges, the ₹3,150 crore capital injection by Advent International will be structured as a primary investment. The funds are being deployed through a preferential allotment comprising fresh equity shares and convertible warrants. Upon closing of the regulatory and statutory approval processes, Advent International is projected to control an approximate 24.9% equity stake in the corporate hospital operator. Highlighting the strategic logic behind the transaction, Advent Managing Director Pankaj Patwari noted that the substantial equity deployment demonstrates the PE giant's long-term conviction in India’s fast-expanding healthcare delivery infrastructure. Corroborating the vision, Yatharth Tyagi, Whole-Time Director of Yatharth Hospitals, stated that Advent's deep operational expertise and value-creation capabilities will significantly accelerate the chain's next phase of clinical and geographical expansion.

Promoter Tyagi Family Retains Control as Bed Capacity Nears 3,250

Despite the entry of the global private equity major with a significant minority holding, the founding Tyagi family will continue to remain the single largest shareholder group, ensuring operational and managerial continuity. Established in 2008, Yatharth Hospitals has grown from a regional clinical operator into an expansive multi-specialty network across northern India. The company currently manages a portfolio of nine advanced multi-specialty hospitals with roughly 2,800 fully operational beds, while its aggregate declared infrastructure capacity stands at approximately 3,250 beds. The fresh primary proceeds are widely anticipated to fund brownfield expansions, upgrade high-end robotic surgical equipment, and support strategic acquisitions of tertiary care assets in high-density urban clusters.

Multi-Bagger Returns: Stock Rallies 59% in 2026 and 177% Over Three Years

The latest 10% surge caps an exceptional multi-timeframe rally for the hospital operator's equity investors. Yatharth Hospital shares have jumped over 27% in the past month alone, while its calendar year-to-date return for 2026 has climbed to an impressive 59%. Over a broader three-year horizon, the stock has delivered multi-bagger returns of 177%, outperforming the benchmark Nifty Healthcare Index. Thursday's peak of ₹1,083.6 represents a doubling in value from its 52-week low of ₹538 recorded on January 27 of this year, positioning the counter as one of the standout mid-cap healthcare performers on Dalal Street.